Let's Talk Quality4 Sep 2024

Irving Ford on leading Adaptimmune through FDA approval and commercialisation of their T cell therapy, Tecelra.

We are back for Season Two of Lets Talk Quality!

This week, I had the pleasure of speaking with Irving Ford, VP of Quality at Adaptimmune Therapeutics.

Irving has been through the commercialisation of four cell therapy products, most recently leading Adaptimmune through the BLA and FDA approval of their engineered T cell for solid tumour, Tecelra.

Irving talks about his journey from starting out his career as a Microbiologist before making his transition into the pharmaceutical industry. He started in a generics company which exposed him to a variety of product types. He worked his way up into leadership positions, across multiple different aspects of quality, to get to where he is now.

Takeaways

The benefit of working in multiple aspects of quality in your early career
Developing trust and building leadership capabilities
Developing different generations of people
Putting yourself out of your comfort zone in your career
Key ingredients for moving from clinical to commercial operations in cell therapy
Unlearning everything you've learnt when working in cell therapy
Training for mindset and continuous development
Managing stress, workload and your emotions
Irving's values, views on legacy, inspiration, and advice for future leaders!

Chapters

00:00 Introduction and Overview of Irving Ford
03:00 Transitioning from Clinical to Commercial Operations
11:33 Building Strong Relationships and Creating a Positive Work Culture
19:24 Challenges and Real-Time Decision Making in Cell Therapy
25:30 Personal Values and Leaving a Legacy
32:18 Advice for Future Quality Leaders

Huge thank you to Irving for giving us his time!

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(78)

My Thoughts on Quality Leadership, Halfway Through Season Four

Season Four is at its halfway point, so instead of a guest this week I’ve gone back over the conversations so far and pulled out the theme that came up most often.The quality leader whose main functio...

30 Juli 16min

Speaking the Language of the Business, with Jamey Lindholm

Quality culture isn't built by SOPs. It's built in the small moments when a leader reinforces the right behaviour or lets the wrong one slide.Speaking the Language of the Business, with Jamey Lindholm...

21 Juli 38min

The Big Pharma Habits You Have to Unlearn in a Startup, with Dawn Lundin

Twenty years at Merck, then a leap into academia and psychedelic medicine - here is how Dawn Lundin built a quality career on instinct.Dawn Lundin on the big pharma habits you have to unlearn in a sta...

14 Juli 29min

How Quality Stopped Being Black and White, with Tim Mitchell

Forty seven years in quality, and Tim Mitchell says the job he started is nothing like the one he does today.Tim Mitchell on how quality stopped being black and whiteIn today's episode I was joined by...

7 Juli 33min

Swetha Krishnan on her journey from Individual Contributor to Inspiring People Leader

She came to the US with her first year's tuition and figured the rest out from there. What followed is one of the most grounded quality leadership journeys I have heard - and one we felt was worth bri...

26 Maj 41min

Building Quality That Scales, with Laura Singer

What does it really take to build a quality organization from the ground up - and do it again, and again, across multiple companies? Laura Singer on building quality that scales.In today's episode I w...

19 Maj 35min

From Virologist to CTO: Leading Quality Through Crisis, with Kimberly Garko

From the lab bench to the C-Suite - and every crisis in between.In today's episode I was joined by Kimberly Garko, former Senior Vice President and Chief Technical Officer at Akebia Therapeutics.I rea...

12 Maj 37min

Three BLAs, Three Journeys, with Irving Ford, Megan Callan, and Jake Treese

Three BLAs. Three companies. One industry-defining challenge.Jake Trees, Irving Ford, and Megan Callan on What It Really Takes to Cross the Commercial Line in Cell and Gene TherapyIn this special comp...

7 Maj 34min